Drug Approval | August 17, 2023
Glenmark Pharmaceuticals receives sANDA approval for Tacrolimus Ointment, 0.03%
Glenmark's current portfolio consists of 184 products authorized for distribution in the U.S. marketplace
Glenmark's current portfolio consists of 184 products authorized for distribution in the U.S. marketplace
Combination creates an integrated provider of drug development and regulatory consulting services serving a complementary client base
Ryan has nearly 20 years of global legal and IP expertise in the pharmaceutical industry
Senvelgo is the first liquid once-daily, orally administered prescription medication to improve glycemic control in cats with diabetes mellitus
Collaboration combines clinical research expertise with artificial intelligence capabilities to help drug developers better understand the probability of clinical success for their assets
ELREXFIO’s label contains a boxed warning for cytokine release syndrome and neurologic toxicity
Deep Transcranial Magnetic Stimulation (dTMS) is a non-invasive brain stimulation technique approved by regulatory authorities, including the USFDA
This is the 166th ANDA out of Eugia Pharma Speciality Group facilities
Continuous learning is not just an option but a responsibility that every healthcare professional must shoulder
Panacea Biotec has reported total income of Rs. 135.27 crores during the period ended June 30, 2023
Subscribe To Our Newsletter & Stay Updated
